1. Home
  2. VERU vs LVLU Comparison

VERU vs LVLU Comparison

Compare VERU & LVLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veru Inc.

VERU

Veru Inc.

N/A

Current Price

$2.63

Market Cap

48.2M

Sector

Health Care

ML Signal

N/A

Logo Lulu's Fashion Lounge Holdings Inc.

LVLU

Lulu's Fashion Lounge Holdings Inc.

N/A

Current Price

$15.08

Market Cap

46.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
VERU
LVLU
Founded
1971
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
48.2M
46.7M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
VERU
LVLU
Price
$2.63
$15.08
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$22.50
N/A
AVG Volume (30 Days)
278.7K
19.3K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,296,958.00
$282,284,000.00
Revenue This Year
N/A
$5.66
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.05
$3.67
52 Week High
$7.33
$32.32

Technical Indicators

Market Signals
Indicator
VERU
LVLU
Relative Strength Index (RSI) 54.95 48.97
Support Level $2.12 $13.59
Resistance Level $2.67 $16.56
Average True Range (ATR) 0.14 1.71
MACD 0.06 -0.60
Stochastic Oscillator 65.75 15.24

Price Performance

Historical Comparison
VERU
LVLU

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

About LVLU Lulu's Fashion Lounge Holdings Inc.

Lulus Fashion Lounge Holdings Inc is a fashion brand serving Millennial and Gen Z women. Its products include Fall Dresses, Winter Dresses, Sweater Dresses, Short Dresses, Casual Dresses, Wedding Dresses, and Denims, among others. The company generates the majority of its revenue from customers based in the United States.

Share on Social Networks: